These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 8050089

  • 1. Characterisation of a recombinant Fv fragment of anti-MUC1 antibody HMFG1.
    Davies GM, Bösze S, Hudecz F, Price MR, Tendler SJ.
    Cancer Lett; 1994 Jul 29; 82(2):179-84. PubMed ID: 8050089
    [Abstract] [Full Text] [Related]

  • 2. Peptide epitope binding and fluorescence quenching with the anti-mucin antibody C595.
    Scanlon MJ, Price MR, Tendler SJ.
    Cancer Lett; 1992 Apr 30; 63(3):199-202. PubMed ID: 1374287
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity.
    Mazor Y, Keydar I, Benhar I.
    Mol Immunol; 2005 Jan 30; 42(1):55-69. PubMed ID: 15488944
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A novel monoclonal antibody, H9, directed against the core protein of MUC1 mucin.
    Hamada H, Kohno N, Yokoyama A, Kondo K, Yang SZ, Hiwada K, Watanabe K, Miyake M.
    Oncol Rep; 2000 Jan 30; 7(2):225-32. PubMed ID: 10671662
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P, Kandilogiannaki M, Petrarca C, von Mensdorff-Pouilly S, Hilgers JH, Krambovitis E, Arends JW, Hoogenboom HR.
    Cancer Res; 1998 Oct 01; 58(19):4324-32. PubMed ID: 9766660
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
    Baeckström D, Nilsson O, Price MR, Lindholm L, Hansson GC.
    Cancer Res; 1993 Feb 15; 53(4):755-61. PubMed ID: 7679050
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and antibody recognition of mucin 1 (MUC1)-alpha-conotoxin chimera.
    Drakopoulou E, Uray K, Mezö G, Price MR, Vita C, Hudecz F.
    J Pept Sci; 2000 Apr 15; 6(4):175-85. PubMed ID: 10809390
    [Abstract] [Full Text] [Related]

  • 19. Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system.
    Asano R, Takemura S, Tsumoto K, Sakurai N, Teramae A, Ebara S, Katayose Y, Shinoda M, Suzuki M, Imai K, Matsuno S, Kudo T, Kumagai I.
    J Biochem; 2000 Apr 15; 127(4):673-9. PubMed ID: 10739961
    [Abstract] [Full Text] [Related]

  • 20. Preparation of the Fv fragment from a short-chain mouse IgG2a anti-dansyl monoclonal antibody and use of selectively deuterated Fv analogues for two-dimensional 1H NMR analyses of the antigen-antibody interactions.
    Takahashi H, Igarashi T, Shimada I, Arata Y.
    Biochemistry; 1991 Mar 19; 30(11):2840-7. PubMed ID: 1901020
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.